Woodchuck hepatitis virus replication and antigen expression gradually decrease in preneoplastic hepatocellular lineages

Journal of Hepatology

Volumn 37, Issue 4, 2002, Pages 478-485

  Li, Yanhua ^a   Hacker, Hans Jörg ^a   Kopp Schneider, Annette ^a   Protzer, Ulrike ^b   Bannasch, Peter ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Hepadnaviral hepatocarcinogenesis; Hepatocellular neoplasms; Insulin glucagon imbalance; Preneoplastic hepatocellular foci; Woodchuck hepatitis virus antigen expression; Woodchuck hepatitis virus DNA

Indexed keywords

AFLATOXIN B1; GLUCAGON; INSULIN; MEMBRANE ANTIGEN; VIRUS ANTIGEN; VIRUS DNA; GLYCOGEN; HEPATITIS B ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BASOPHIL; CONTROLLED STUDY; HEPATITIS VIRUS; IN SITU HYBRIDIZATION; INOCULATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER PARENCHYMA; NEWBORN; NONHUMAN; PRIORITY JOURNAL; VIRUS REPLICATION; WOODCHUCK; ANIMAL; CELL LINEAGE; CHEMISTRY; CYTOLOGY; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; LIVER ADENOMA; LIVER CELL; LIVER TUMOR; PATHOLOGY; PRECANCER; SCIURIDAE; VIROLOGY;

ADENOMA, LIVER CELL; ANIMALS; CELL LINEAGE; DNA, VIRAL; GLYCOGEN; HEPATITIS B ANTIGENS; HEPATITIS B VIRUS, WOODCHUCK; HEPATITIS B, CHRONIC; HEPATOCYTES; IN SITU HYBRIDIZATION; LIVER NEOPLASMS; MARMOTA; PRECANCEROUS CONDITIONS; VIRUS REPLICATION;

EID: 0036784098     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(02)00233-7     Document Type: Article

References (58)

1. Montesano R, Hainaut P, Wild CP. Hepatocellular carcinoma: from gene to public health. J Natl Cancer Inst 1997;89:1844-1851.
2. Qian GS, Ross RK, Yu MC, Yuan JM, Gao YT, Henderson BE, Wogan GN, Groopman JD. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev 1994;3:3-10.
3. IARC. Hepatitis B virus. IARC monographs on the evaluation of carcinogenic risks to humans, Lyon: International Agency for Research on Cancer, 1994. pp. 45-255.
4. IARC. Aflatoxins. IARC monographs on the evaluation of carcinogenic risks to humans. Lyon: International Agency for Research on Cancer, 1993. pp. 245-395.
5. Lieberman HM, Shafritz D. Persistent hepatitis B virus infection and hepatocellular carcinoma. Prog Liver Dis 1986;8:395-415.
6. Buendia MA. Hepatitis B viruses and hepatocellular carcinoma. Adv Cancer Res 1992;59:167-226.
7. Rogler CE, Rogler LE, Yang D, Breiteneder-Geleef S, Gong S, Wang H. Contributions of hepadnavirus research to our understanding of hepatocarcinogenesis. In: Jirtle RL, editor. Liver regeneration and carcinogenesis, San Diego, CA: Academic Press, 1995. pp. 113-140.
8. Popper H, Roth L, Purcell RH, Tennant BC, Gerin JL. Hepatocarcinogenicity of the woodchuck hepatitis virus. Proc Natl Acad Sci USA 1987;84:866-870.
9. Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S, et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 1989;59:1145-1156.
10. Kim CM, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991;351:317-320.
11. Toshkov I, Chisari FV, Bannasch P. Hepatic preneoplasia in hepatitis B virus transgenic mice. Hepatology 1994;20:1162-1172.
12. Bannasch P, Imani NK, Hacker HJ, Radaeva S, Mrozek M, Zillmann U, et al. Synergistic hepatocarcinogenic effect of hepadnaviral infection and dietary aflatoxin B1 in woodchucks. Cancer Res 1995;55:3318-3330.
13. Dandri M, Schirmacher P, Rogler CE. Woodchuck hepatitis virus X protein is present in chronically infected woodchuck liver and woodchuck hepatocellular carcinomas which are permissive for viral replication. J Virol 1996;70:5246-5254.
14. Hildt E, Saher G, Brass V, Hofschneider PH. The hepatitis B virus large surface protein (LHBs) is a transcriptional activator. Virology 1996;225:235-239.
15. Koike K. Hepatitis B virus HBx gene and hepatocarcinogenesis. Intervirology 1995;38:134-142.
16. Caselmann WH. Trans-activation of cellular genes by hepatitis B virus proteins: a possible mechanism of hepatocarcinogenesis. Adv Virus Res 1996;47:253-302.
17. Feitelson MA, Duan LX. Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Am J Pathol 1997;150:1141-1157.
18. Etiemble J, Degott C, Renard CA, Fourel G, Shamoon B, Vitvitski Trepo L, et al. Liver-specific expression and high oncogenic efficiency of a c-myc transgene activated by woodchuck hepatitis virus insertion. Oncogene 1994;9:727-737.
19. Liu P, Terradillos O, Renard CA. Feldmann G, Buendia MA, Beruuau D. Hepatocaroinogenesis in woodchuck hepatitis virus/c-myc mice: sustained cell proliferation and biphasic activation of insulin-like growth factor II. Hepatology 1997;25:874-883.
20. Bannasch P. Pathogenesis of hepatocellular carcinoma: sequential cellular, molecular, and metabolic changes. Prog Liver Dis 1996;14:161-197.
21. Farber E. The step-by-step development of epithelial cancer: from phenotype to genotype. Adv Cancer Res 1996;70:21-48.
22. Bannasch P, Zerban H. Experimental chemical hepatocarcinogenesis. In: Okuda K, Tabor E, editors. Liver cancer, New York: Churchill Livingstone, 1997, pp. 213-253.
23. Mayer D, Metzger C, Leonetti P, Beier K, Benner A, Bannasch P. Differential expression of key enzymes of energy metabolism in preneoplastic and neoplastic rat liver lesions induced by N-nitrosomorpholine and dehydroepiandrosterone. Int J Cancer (Pred Oncol) 1998;79:232-240.
24. Abe K, Kurata T, Shikata T, Tennant BC. Enzyme-altered liver cell foci in woodchucks infected with woodchuck hepatitis virus. Jpn J Cancer Res 1988;79:466-472.
25. Toshkov I, Hacker HJ, Roggendorf M, Bannasch P. Phenotypic patterns of preneoplastic and neoplastic hepatic lesions in woodchucks infected with woodchuck hepatitis virus. J Cancer Res Clin Oncol 1990;116:581-590.
26. Yang D, Alt E, Rogler CE. Coordinate expression of N-myc 2 and insulin-like growth factor II in precancerous altered hepatic foci in woodchuck hepatitis virus carriers. Cancer Res 1993;53:2020-2027.
27. Mi LJ, Patil J, Horubuckle WE, Cote PJ, Gerin JL, Tennant BC, Paronetto F. DNA ploidy analysis of hepatic preneoplastic and neoplastic lesions in woodchucks experimentally infected with woodchuck hepatitis virus. Hepatology 1994;20:21-29.
28. Jacob JR, Ascenzi MA, Roneker CA, Toshkov IA, Cote PJ, Gerin JL, Tennant BC. Hepatic expression of the woodchuck hepatitis virus X-antigen during acute and chronic infection and detection of a woodchuck hepatitis virus X-antigen antibody response. Hepatology 1997;26:1607-1615.
29. Radaeva S, Li Y, Hacker HJ, Burger V, Kopp-Schneider A, Bannasch P. Hepadnaviral hepatocarcinogenesis: in situ visualization of viral antigens, cytoplasmic compartmentation, enzymic patterns, and cellular proliferation in preneoplastic hepatocellular lineages in woodchucks. J Hepatol 2000;33:580-600.
30. Su Q, Benner A, Hofmann WJ, Otto G, Pichlmayr R, Bannasch P. Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia. Virchows Arch 1997;431:391-406.
31. Su Q, Schröder C, Hofmann W, Otto G, Pichlmayr R, Bannasch P. Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology 1998;27:1109-1120.
32. Su Q, Zerban H, Otto G, Bannasch P. Cytokeratin expression is reduced in glycogenotic hepatocytes but increased in ground glass cells in chronic human and woodchuck hepadnaviral infection. Hepatology 1998;28:347-359.
33. Su Q, Schröder CH, Otto G, Bannasch P. Overexpression of p53 is not directly related to hepatitis B x protein expression and is associated with neoplastic progression rather than hepatic preneoplasia. Mutation Res 2000;462:365-380.
34. SAS Institute. PROC NPARIWAYSAS version 6.12. Cary. NC: SAS Institute
35. 1-Behandlung. Thesis. Giessen, Germany: University of Giessen, 1998.
36. Blum HE, Haase AT, Vyas GN. Molecular pathogenesis of hepatitis B virus infection: simultaneous detection of viral DNA and antigens in paraffin-embedded liver sections. Lancet 1984;2:771-775.
37. Fourel G, Trepo C, Bougueleret L, Henglein B, Ponzetto A, Tiollais P, Buendia MA. Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours. Nature 1990;347:294-298.
38. Yang DY, Rogler CE. Analysis of insulin-like growth factor II (IGF-II) expression in neoplastic nodules and hepatocellular carcinomas of woodchucks utilizing in situ hybridization and immunohistochemistry. Carcinogenesis 1991;12:1893-1901.
39. Michalak TI, Lin B. Molecular species of hepadnavirus core and envelope polypeptides in hepatocyte plasma membrane of woodchucks with acute and chronic viral hepatitis. Hepatology 1994;20:275-286.
40. Michalak TI, Pardoe IU, Coffin CS, Churchill ND, Freake DS, Smith P, Trelegan CL. Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis. Hepatology 1999;29:928-938.
41. Hirohashi S, Shimasato Y, Ino Y, Kishi K. Distribution of hepatitis B surface and core antigens in human liver cell carcinoma and surrounding nontumorous liver. J Natl Cancer Inst 1982;69:565-568.
42. Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. Nature 1985;317:489-495.
43. Raimondo G, Burk RD, Lieberman HM, Muschel J, Hadziyannis SJ, Will H, et al. Interrupted replication of hepatitis B virus in liver tissue of HBsAg carriers with hepatocellular carcinoma. Virology 1988;166:103-112.
44. Paterlini P, Poussin K, Kew M, Franco D, Bréchot C. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 1995;21:313-321.
45. Poussin K, Dienes H, Sirma H, Urban ST, Beaugrand M, Franco D, et al. Expression of mutated hepatitis B virus X genes in human hepatocellular hepatomas. Int J Cancer 1999;80:497-505.
46. Zhu M, London WT, Duan L-X, Feitelson MA. The value of hepatitis B x antigen as a prognostic marker in the development of hepatocellular carcinoma. Int J Cancer 1993;55:571-576.
47. Mendy ME, Fortuin M, Hall AJ, Jack AD, Whittle HC. Hepatitis B virus DNA in relation to duration of hepatitis B surface antigen carriage. Br J Biomed Sci 1999;56:34-38.
48. Galle PR, Schlicht HJ, Kuhn C, Schaller H. Replication of duck hepatitis B virus in primary duck hepatocytes and its dependence on the state of differentiation of the host cell. Hepatology 1989;10: 459-465.
49. Ozer A, Khaoustov VI, Mearns M, Lewis DE, Genta RM, Darlington GJ, Yoffe B. Effect of hepatocyte proliferation and cellular DNA synthesis on hepatitis B virus replication. Gastroenterology 1996;110:1519-1528.
50. Kairat A, Beerheide W, Zhou G, Tang Z-Y, Edler L, Schröder CH. Truncated hepatitis B virus RNA in human hepatocellular carcinoma: its representation in patients with advancing age. Intervirology 1999;42:228-237.
51. Hild M, Weber O, Schaller H. Glucagon treatment interferes with an early step of duck hepatitis B virus infection. J Virol 1998;72:2600-2606.
52. Chou CK, Su TS, Chang CM, Hu CP, Huang MY, Suen CS, et al. Insulin suppresses hepatitis B surface antigen expression in human hepatoma cells. J. Biol. Chem. 1989;246:15304-15308.
53. Lin YL, Chen HC, Yeh SF, Chou CK. Differential pathways of insulin action upon the hepatitis B surface antigen gene expression and cell proliferation in human hepatoma cells. Endocrinology 1995;136:2922-2927.
54. Bannasch P, Klimek F, Mayer D. Early bioenergetic changes in hepatocarcinogenesis: preneoplastic phenotypes mimic responses to insulin and thyroid hormone. J Bioenerg Biomembr 1997;29:303-313.
55. Nehrbass D. Klimek F, Bannasch P. Overexpression of insulin receptor substrate-1 emerges early in hepatocarcinogenesis and elicits preneoplastic hepatic glycogenolysis. Am J Pathol 1998;152:341-345.
56. Bannasch P, Kopp-Schneider A, Nehrbass D. Significance of hepatic preneoplasia for cancer chemoprevention, Lyon: IARC Scientific Publications, 2002. pp. 223-240.
57. Weber E, Bannasch P. Dose- and time-dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by continuous oral exposure to N-nitrosomorpholine. Carcinogenesis 1994;15:1235-1242.
58. Kopp-Schneider A, Pottier C, Bannasch P. A model for hepatocarcinogenesis treating phenotypical changes in focal hepatocellular lesions as epigenetic events. Math Biosci 1998;148:181-204.